Abnormal Security Launches Limited Web Series on the Convergence of AI + Cybersecurity, Featuring Kevin Poulsen and Zack Kass
Abnormal Security, the leading behavioral AI-based email security platform, today announced the launch of its limited web series titled The Convergence of AI + Cybersecurity. Presented by Fast Company and co-sponsored by CrowdStrike and GuidePoint Security, this series will dive into the threat presented by generative AI and provide insight into how security leaders can protect their organizations.
There is little doubt that AI and cybersecurity are colliding now more than ever. The positive power of AI is apparent with increased efficiency, cost savings and more. Unfortunately, the same is true when those benefits get into the wrong hands. This limited series will unpack how cybercriminals can use generative AI tools like ChatGPT to scale their attacks, and will provide attendees with insights into how leading organizations are using good AI to defend against the threat of bad AI.
Facing Your Fears: A Live Demo on How Attackers Can Use Generative AI
Tuesday, October 3 - 2:00 pm ET
In this session, former black hat hacker Kevin Poulsen will provide a live demo on how ChatGPT and other generative AI tools can be used by bad actors to create sophisticated attacks. He'll be joined by Abnormal CISO Mike Britton and threat researcher Ronnie Tokazowski.
Fighting AI with AI: A CISO Panel on Security Best Practices
Tuesday, October 24 - 2:00 pm ET
This session will include best practices from CISOs, showcasing how they're securing their organizations against the threat of generative AI. Speakers include CISOs Patrick Hellman of Arrow Electronics and Gary Brickhouse of GuidePoint Security, as well as Stephen Ward, managing director at Insight Partners and former CISO of Home Depot.
Securing the Future with AI: A Discussion Among Leading AI Experts
Tuesday, November 14 - 2:00 pm ET
The final session will discuss why organizations need to solve the problems caused by bad AI with an equally powerful tool?good AI. This panel will be led by Zack Kass, technology futurist and the head of go-to-market strategy for OpenAI. He'll be joined by two other AI strategists: Evan Reiser, CEO of Abnormal Security, and a speaker from CrowdStrike.
All three chapters will be recorded for future viewing. Attendees can register here for one or all of the sessions.
AI is dramatically changing the security landscape, and we must be prepared. In addition to the limited web series, Abnormal is hosting an executive roadshow, where attendees can discuss this convergence over dinner. These events provide the perfect opportunity for security leaders to understand the threat of AI, engage with industry peers, and prepare their own organizations for the future.
Abnormal Security provides the leading behavioral AI-based email security platform that leverages machine learning to stop sophisticated inbound email attacks and dangerous email platform attacks that evade traditional solutions. The anomaly detection engine leverages identity and context to analyze the risk of every cloud email event, preventing inbound email attacks, detecting compromised accounts, and remediating emails and messages in milliseconds?all while providing visibility into configuration drifts across your environment. You can deploy Abnormal in minutes with an API integration for Microsoft 365 or Google Workspace and experience the full value of the platform instantly, with additional protection available for Slack, Teams, and Zoom. More information is available at abnormalsecurity.com.
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...